Evidence map›Paper›PMID 41023422›Full record

ArticleMolecular psychiatry2026

Development and validation of a prognostic model and risk calculator for the estimation of bipolar-spectrum disorder risk in hospitalised adolescents with non-psychotic/non-bipolar mental disorders.

Gonzalo Salazar de Pablo, Joaquim Radua, Grace Frearson, Allan H Young, Celso Arango, Ian Kelleher, Aditya Sharma, Peter J Uhlhaas, Marco Solmi, Paolo Fusar-Poli and 2 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gonzalo Salazar de Pablo *Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0002-6992-0767
Joaquim Radua *IMARD Group, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0003-1240-5438
Grace FrearsonDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Allan H YoungCentre for Affective Disorders (CfAD), Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.ORCID 0000-0003-2291-6952
Celso ArangoHospital Universitario La Paz, IdiPAZ, School of Medicine Universidad Autónoma de Madrid, CIBERSAM, Madrid, Spain.ORCID 0000-0003-3382-4754
Ian KelleherCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1484-651X
Aditya SharmaAcademic Psychiatry, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Peter J UhlhaasDepartment of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.ORCID 0000-0002-0892-2224
Marco SolmiDepartment of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.ORCID 0000-0003-4877-7233
Paolo Fusar-PoliEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0003-3582-6788
Daniel GuinartDepartment of Psychiatry, Hospital del Mar, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.ORCID 0000-0001-5078-6716
Christoph U CorrellDepartment of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany. ccorrell@northwell.edu.ORCID 0000-0002-7254-5646

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to develop and validate a risk estimation model for developing bipolar-spectrum disorders (BSD) in psychiatrically hospitalized adolescents based on clinical characteristics, including putatively prodromal symptoms. Adolescent inpatients (ages = 12-18 years) with non-psychotic/non-BSD diagnoses were recruited for the Adolescent Mood Disorder and Psychosis Study (AMDPS), a longitudinal, prospective 5-year follow-up cohort. We assessed prevalence and severity of syndromal/subsyndromal psychopathology at baseline using the validated Bipolar Prodrome Symptom Interview and Scale-Prospective. We carried out machine learning analyses (Lasso-Cox regression analyses, LCR) to create a calculator to estimate the risk of developing BSD based on baseline demographic/comorbidity/illness/treatment characteristics. Of 105 adolescents (age = 15.6 ± 1.3 years, females = 72.4%), we observed that 18 developed BSD. The cumulated estimated risk of BSD was 5/22/29/36% at 1/2/3/4 years. BSD development was associated with presence of persistent depressive disorder (HR = 4.0, p < 0.018) at baseline, treatment with mood stabilizers (hazard ratio (HR) = 3.9, p = 0.006), and ADHD medications (HR = 3.3, p = 0.023). BSD development risk estimation calculator included the prevalence of inflated self-esteem/grandiosity (β = 0.83) and racing thoughts (β = 0.08) and the severity of overtalkativeness (β = 0.03) and increased energy (β = 0.04). For predicting BSD onset within the first 20 months, the area under the receiver operating characteristic curve (AUC) indicated acceptable to strong discrimination (cross-validation AUC = 0.72; bootstrap out-of-bag validation AUC = 0.86). Codes used in this study are provided in the R package "easy.glmnet". In conclusion, in this prognostic model/calculator, presence and severity of subthreshold (hypo)mania-like symptoms conferred increased risk of BSD development in youth, informing preventive efforts to identify individuals at risk for BSD and improve their outcomes.

Indexed as

Bipolar DisorderAdolescentChildFemaleHospitalizationHumansLongitudinal StudiesMachine LearningMaleMental DisordersPrevalenceProdromal SymptomsPrognosisProspective StudiesPsychotic DisordersRisk Assessment

Identifiers

PMID41023422
PMCPMC12916283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.